Clinical trials
Terminated Glomerulonephritis, IGA trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 2 |
| Omeros Corporation | 2 |
| Alnylam Pharmaceuticals | 1 |
| Aravive, Inc. | 1 |
| BioCryst Pharmaceuticals | 1 |
| Columbia University | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eledon Pharmaceuticals | 1 |
| Guangdong Hengrui Pharmaceutical Co., Ltd | 1 |
| Nanjing University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis, IGA | 16 |
| Proteinuria | 6 |
| Glomerulonephritis, Membranous | 3 |
| Lupus Nephritis | 3 |
| Glomerulonephritis | 2 |
| Kidney Diseases | 2 |
| Acute Kidney Injury | 1 |
| Diabetic Nephropathies | 1 |
| Glomerulonephritis, Membranoproliferative | 1 |
| Glomerulosclerosis, Focal Segmental | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.